Cargando…

CD33 Expression and Gentuzumab Ozogamicin in Acute Myeloid Leukemia: Two Sides of the Same Coin

SIMPLE SUMMARY: Roughly 85–90% of adult and pediatric acute myeloid leukemia (AML) are CD33-positive. Gemtuzumab ozogamicin (GO), a humanized murine IgG4 anti-CD33 antibody, is the first target therapy approved in AML therapeutic scenario. This review focuses on current biological information and cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Molica, Matteo, Perrone, Salvatore, Mazzone, Carla, Niscola, Pasquale, Cesini, Laura, Abruzzese, Elisabetta, de Fabritiis, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268215/ https://www.ncbi.nlm.nih.gov/pubmed/34203180 http://dx.doi.org/10.3390/cancers13133214

Ejemplares similares

Ara-C, Idarubicine and Gentuzumab Ozogamicin (AIM) as Salvage Treatment in Advanced Acute Myeloid Leukemia Patients
por: Capria, Saveria, et al.
Publicado: (2012)

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
por: Molica, Matteo, et al.
Publicado: (2021)

CPX-351: An Old Scheme with a New Formulation in the Treatment of High-Risk AML
por: Molica, Matteo, et al.
Publicado: (2022)

Case Report: Very Late, Atypical Extra-Medullary Relapse in a Patient With Acute Promyelocytic Leukemia (APL) Rescued With a Transplant-Free Approach
por: Molica, Matteo, et al.
Publicado: (2021)

PB2033: ADVANCED CHRONIC MYELOMONOCYTIC LEUKEMIA IN ELDERLY AND FRAIL PATIENTS MANAGED BY AZACITIDINE IN THE FIELD OF CLINICAL PRACTICE.
por: Niscola, Pasquale, et al.
Publicado: (2023)

Idiopathic Osteoporosis and Nephrolithiasis: Two Sides of the Same Coin?
por: Rendina, Domenico, et al.
Publicado: (2020)

Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin
por: Yu, Shunjie, et al.
Publicado: (2022)

“Comorbidity” between epilepsy and headache/migraine: the other side of the same coin!
por: Striano, Pasquale, et al.
Publicado: (2011)

Are hemostasis and thrombosis two sides of the same coin?
por: Colman, Robert W.
Publicado: (2006)

Hormesis: Decoding Two Sides of the Same Coin
por: Bhakta-Guha, Dipita, et al.
Publicado: (2015)

Neutrophils in Cancer: Two Sides of the Same Coin
por: Uribe-Querol, Eileen, et al.
Publicado: (2015)

Multimorbidity or polypharmacy: two sides of the same coin?
por: Sinnott, Carol, et al.
Publicado: (2015)

Creativity and psychopathology: Two sides of the same coin?
por: Reddy, Indla Ramasubba, et al.
Publicado: (2018)

Cancer and dementia: Two sides of the same coin?
por: van der Willik, Kimberly D., et al.
Publicado: (2018)

Aging and Metabolism: Two Sides of the Same Coin
Publicado: (2017)

Cancer and neurodegeneration: two sides, same coin?
por: Garcia-Ratés, Sara, et al.
Publicado: (2017)

Propositionalization and embeddings: two sides of the same coin
por: Lavrač, Nada, et al.
Publicado: (2020)

On Naevi and Melanomas: Two Sides of the Same Coin?
por: Lee, Katie J., et al.
Publicado: (2021)

Autoimmunity and Cancer—Two Sides of the Same Coin
por: Sakowska, Justyna, et al.
Publicado: (2022)

Patient and public involvement: Two sides of the same coin or different coins altogether?
por: McCoy, Matthew S., et al.
Publicado: (2019)

Cancer Metabolism and Ischemia-Reperfusion Injury: Two Sides of the Same Coin
por: Nemeth, Denise V., et al.
Publicado: (2022)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

Fear and Courage in Children: Two Sides of the Same Coin?
por: Muris, Peter
Publicado: (2009)

Sarcopenia and Physical Frailty: Two Sides of the Same Coin
por: Cesari, Matteo, et al.
Publicado: (2014)

Refeeding and metabolic syndromes: two sides of the same coin
por: Obeid, O A, et al.
Publicado: (2014)

Hypericin in the Light and in the Dark: Two Sides of the Same Coin
por: Jendželovská, Zuzana, et al.
Publicado: (2016)

HOXs and lincRNAs: Two sides of the same coin
por: De Kumar, Bony, et al.
Publicado: (2016)

Acute Hepatitis E: Two Sides of the Same Coin
por: Hartl, Johannes, et al.
Publicado: (2016)

Aging and Parkinson’s Disease: Different Sides of the Same Coin?
por: Collier, Timothy J., et al.
Publicado: (2017)

NF-kappaB: Two Sides of the Same Coin
por: Pires, Bruno R. B., et al.
Publicado: (2018)

Editorial: Insight and Intuition – Two Sides of the Same Coin?
por: Öllinger, Michael, et al.
Publicado: (2018)

Superiority and non-inferiority: two sides of the same coin?
por: Dunn, David T., et al.
Publicado: (2018)

Are Proteinopathy and Oxidative Stress Two Sides of the Same Coin?
por: Mehta, Nihar J., et al.
Publicado: (2019)

Intelligence and Cognitive Development: Three Sides of the Same Coin
por: de Ribaupierre, Anik, et al.
Publicado: (2017)

Viruses and autoimmune disease – two sides of the same coin?
por: Fujinami, Robert S.
Publicado: (2001)

Sepsis and antimicrobial stewardship: two sides of the same coin
por: Fitzpatrick, Fidelma, et al.
Publicado: (2019)

Autophagy in Multiple Sclerosis: Two Sides of the Same Coin
por: Misrielal, Chairi, et al.
Publicado: (2020)

Genetics and Autoimmunity: Two Sides of the Same Coin or an Epiphenomenon?
por: Chatterjee, Rudrarpan, et al.
Publicado: (2022)

β-Lactoglobulin and Glycodelin: Two Sides of the Same Coin?
por: Sawyer, Lindsay
Publicado: (2021)

Hyperlipidemia and Platelet Parameters: Two Sides of the Same Coin
por: Singh, Anurag, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_v656tp2rucs5ukbtkanhbgfio1